Clinical Trial Update: A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias [Phase 1]

View source ↗

Summary

Phase I study evaluating NK cell infusions after allogeneic stem cell transplantation in pediatric leukemia and lymphoma patients has completed and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2019-08-22